CLINICAL_TRIALS
trial_result
· 2024-01-18
Clinical Trial Update: A Clinical Trial of Retinal Gene Therapy for X-linked Retinitis Pigmentosa Using BIIB112 [Phase 1, Phase 2]
Summary
Phase 1/2 clinical trial update for BIIB112 retinal gene therapy in X-linked retinitis pigmentosa has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Biogen | Conditions: X-Linked Retinitis Pigmentosa | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2024-01-18